The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs

BACKGROUNDS: Recent clinical trials have shown that immune-checkpoint blockade yields remarkable response in a subset of non–small cell lung cancer (NSCLC) patients. However, few studies directly focus on the association between epidermal growth factor receptor (EGFR) mutational status and programme...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Yanna, Fang, Wenfeng, Zhang, Yaxiong, Hong, Shaodong, Kang, Shiyang, Yan, Yue, Chen, Nan, Zhan, Jianhua, He, Xiaobo, Qin, Tao, Li, Ge, Tang, Wenyi, Peng, Peijian, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546461/
https://www.ncbi.nlm.nih.gov/pubmed/25895031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546461/
https://www.ncbi.nlm.nih.gov/pubmed/25895031

Ejemplares similares